The company is dedicated to maintaining the highest quality and regulatory standards while supporting smooth global business ...

However, the complexity of cell and gene therapy (CGT) manufacturing contributes to low trial to approval success rates. As such, scientists and engineers look for ways to improve and streamline CGT ...

This article is authored by Ranjit Barshikar, CEO, QbD International, CGMP Consulting, United Nations Adviser.